{"id":622247,"date":"2022-10-21T21:04:01","date_gmt":"2022-10-21T21:04:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=622247"},"modified":"2022-10-21T21:04:01","modified_gmt":"2022-10-21T21:04:01","slug":"ophthalmic-equipment-market-worth-809-billion-by-2027-exclusive-report-by-marketsandmarkets","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/ophthalmic-equipment-market-worth-809-billion-by-2027-exclusive-report-by-marketsandmarkets_622247.html","title":{"rendered":"Ophthalmic Equipment Market worth $80.9 billion by 2027 &#8211; Exclusive Report by MarketsandMarkets\u2122"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1666366337.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Ophthalmic Equipment Market worth $80.9 billion by 2027 - Exclusive Report by MarketsandMarkets&trade;\" src=\"https:\/\/www.abnewswire.com\/uploads\/1666366337.jpeg\" alt=\"Ophthalmic Equipment Market worth $80.9 billion by 2027 - Exclusive Report by MarketsandMarkets&trade;\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>The prominent players in the ophthalmic equipment market are Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson and Johnson (US), Hoya Corporation (Japan)<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">In 2022, Alcon acquired Ivantis Inc. to help ensure continuity of the business and relationships with existing customers and allowing Alcon to begin its future growth plans to bring Hydrus Microstent to more international markets.<\/div>\n<p style=\"text-align: justify;\">&nbsp;<strong><a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/ophthalmology-devices-market-155637364.html?utm_source=Abnewswire&amp;utm_medium=referral\" target=\"_blank\">Ophthalmic Equipment Market<\/a>&nbsp;is projected to grow from&nbsp;USD 63.4 billion&nbsp;in 2022 to&nbsp;USD 80.9 billion&nbsp;by 2027, at a CAGR of 5.0% from 2022 to 2027, according to a new report by MarketsandMarkets&trade;.<\/strong>&nbsp;Increasing government initiatives to control visual impairment, technological advancements in ophthalmic devices, and the increasing adoption of contact lenses and spectacles are some of the key factors driving the market for ophthalmic equipment.<\/p>\n<p style=\"text-align: justify;\"><strong>Download PDF Brochure:&nbsp;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=155637364&amp;utm_source=Abnewswire&amp;utm_medium=referral\" target=\"_blank\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=155637364<\/a><\/p>\n<p style=\"text-align: justify;\"><em>Browse in-depth TOC on<\/em><strong>&nbsp;&#8220;Ophthalmic Equipment Market&#8221;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>409 &ndash; Tables<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>58 &ndash; Figures<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>459 &ndash; Pages<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>The vision care products segment accounted for the largest share of the ophthalmic equipment market, by product in 2021<\/strong><\/p>\n<p style=\"text-align: justify;\">Based on products, the ophthalmic equipment market is segmented into vision care products, surgical devices, and diagnostic and monitoring devices. The large share of the vision care products segment is attributed to the growing number of patients with refractive errors, increasing number of wearers, increasing prevalence of myopia, growing geriatric population, and increasing preference for contact lenses over prescription eyeglasses.<\/p>\n<p style=\"text-align: justify;\"><strong>&#8220;Consumer hold the largest share in the ophthalmic equipment market, by end user in 2021&#8221;<\/strong><\/p>\n<p style=\"text-align: justify;\">Based on end users, the market is segmented into consumers, hospitals, specialty clinics and ambulatory surgery centres, and other end users. The large share of consumers can be attributed to increasing emphasis on aesthetics, increasing usage of digital gadgets, growing adoption of spectacles and contact lenses among consumers.<\/p>\n<p style=\"text-align: justify;\"><strong>Request Sample Pages:&nbsp;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=155637364&amp;utm_source=Abnewswire&amp;utm_medium=referral\" target=\"_blank\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=155637364<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>North America&nbsp;accounted for the largest share of the ophthalmic equipment market in 2021<\/strong><\/p>\n<p style=\"text-align: justify;\">In 2021,&nbsp;North America&nbsp;accounted for the largest share the ophthalmic equipments market. Market growth in this region is characterized by the high healthcare expenditure, rising geriatric population (and subsequent growth in the prevalence of eye diseases), and the availability of advanced ophthalmic devices in the country.<\/p>\n<p style=\"text-align: justify;\">The prominent players in the ophthalmic equipment market are Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson and Johnson (US), Hoya Corporation (Japan), The Cooper Companies, Inc.(US), EssilorLuxottica (France), Canon (Japan), Glaukos Corporation (US), Nidek Co., Ltd. (Japan), Topcon Corporation (Japan), Zeimer Ophthalmic Systems (Switzerland), Staar Surgical (US), Haag-Streit (Switzerland), Quantel Medical (US), Coburn Technologies, Inc. (US), FCI Ophthalmics (US), Matronix India Corporation (India), HEINE Optotechnik (Germany), Visionix (France), Neo Vision (Korea), Clear Lab (Singapore), Appasamy Associates (India), Ophtec BV (Netherlands), Lumenis (Israel), and Intuvision Labs (India).<\/p>\n<p style=\"text-align: justify;\"><strong>Get 10% Free Customization on this Report:&nbsp;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/requestCustomizationNew.asp?id=155637364&amp;utm_source=Abnewswire&amp;utm_medium=referral\" target=\"_blank\">https:\/\/www.marketsandmarkets.com\/requestCustomizationNew.asp?id=155637364<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>About MarketsandMarkets&trade;<\/strong>&nbsp;<\/p>\n<p style=\"text-align: justify;\">MarketsandMarkets&trade; provides quantified B2B research on 30,000 high growth niche opportunities\/threats which will impact 70% to 80% of worldwide companies&#8217; revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets&trade; for their painpoints around revenues decisions.<\/p>\n<p style=\"text-align: justify;\">Our 850 fulltime analyst and SMEs at MarketsandMarkets&trade; are tracking global high growth markets following the &#8220;Growth Engagement Model &ndash; GEM&#8221;. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write &#8220;Attack, avoid and defend&#8221; strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets&trade; now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets&trade; is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations\/disruptions early to the market by providing them research ahead of the curve.<\/p>\n<p style=\"text-align: justify;\">MarketsandMarkets&#8217;s flagship competitive intelligence and market research platform, &#8220;Knowledge Store&#8221; connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_17712.html\" rel=\"nofollow\">MarketsandMarkets\u2122 Research Private Ltd.<\/a><br \/><strong>Contact Person:<\/strong> Mr. Aashish Mehra<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=ophthalmic-equipment-market-worth-809-billion-by-2027-exclusive-report-by-marketsandmarkets\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>630 Dundee Road  Suite 430<br \/><strong>City:<\/strong> Northbrook<br \/><strong>State:<\/strong> IL 60062<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/ophthalmology-devices-market-155637364.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/ophthalmology-devices-market-155637364.html<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/ophthalmology-devices-market-155637364.html\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=ophthalmic-equipment-market-worth-809-billion-by-2027-exclusive-report-by-marketsandmarkets\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The prominent players in the ophthalmic equipment market are Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson and Johnson (US), Hoya Corporation (Japan) In 2022, Alcon acquired Ivantis Inc. to help ensure continuity of the &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/ophthalmic-equipment-market-worth-809-billion-by-2027-exclusive-report-by-marketsandmarkets_622247.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,403,404,416],"tags":[],"class_list":["post-622247","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/622247","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=622247"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/622247\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=622247"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=622247"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=622247"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}